These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 36851192)

  • 21. Analyzing COVID-19 Vaccination Side Effects Among the Adult Population in Jeddah, Saudi Arabia.
    Alamri T; Anwer F; Butt NS; Alganmi AH; Alotaibi SA; Alzibali KF; Hawsawi HA; Bakarman M; Malik AA
    Cureus; 2023 Oct; 15(10):e47136. PubMed ID: 37854474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Side Effects and Efficacy of COVID-19 Vaccines among the Egyptian Population.
    Elgendy MO; El-Gendy AO; Mahmoud S; Mohammed TY; Abdelrahim MEA; Sayed AM
    Vaccines (Basel); 2022 Jan; 10(1):. PubMed ID: 35062770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Side effects after COVID-19 vaccinations among residents of Poland.
    Andrzejczak-Grządko S; Czudy Z; Donderska M
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(12):4418-4421. PubMed ID: 34227078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial.
    Kremsner PG; Ahuad Guerrero RA; Arana-Arri E; Aroca Martinez GJ; Bonten M; Chandler R; Corral G; De Block EJL; Ecker L; Gabor JJ; Garcia Lopez CA; Gonzales L; Granados González MA; Gorini N; Grobusch MP; Hrabar AD; Junker H; Kimura A; Lanata CF; Lehmann C; Leroux-Roels I; Mann P; Martinez-Reséndez MF; Ochoa TJ; Poy CA; Reyes Fentanes MJ; Rivera Mejia LM; Ruiz Herrera VV; Sáez-Llorens X; Schönborn-Kellenberger O; Schunk M; Sierra Garcia A; Vergara I; Verstraeten T; Vico M; Oostvogels L;
    Lancet Infect Dis; 2022 Mar; 22(3):329-340. PubMed ID: 34826381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of COVID-19 vaccine booster dose acceptance, reluctance and concerns among elderly diabetes patients in Pakistan.
    Jaweed L; Ahmed Z; Ahmad SA; Imran M; Faraz S; Sahar T; Jaweed J; Maqsood MB; Ahmed S; Iqbal A; Khalid A; Ahmed S; Ishaqui AA
    Pak J Pharm Sci; 2022 Jul; 35(4(Special)):1269-1274. PubMed ID: 36218106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US.
    Hause AM; Zhang B; Yue X; Marquez P; Myers TR; Parker C; Gee J; Su J; Shimabukuro TT; Shay DK
    JAMA Netw Open; 2022 Jul; 5(7):e2222241. PubMed ID: 35838667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What is the Safety of COVID-19 Vaccines in Immunocompromised Patients? Results from the European "Covid Vaccine Monitor" Active Surveillance Study.
    Bellitto C; Luxi N; Ciccimarra F; L'Abbate L; Raethke M; van Hunsel F; Lieber T; Mulder E; Riefolo F; Villalobos F; Thurin NH; Marques FB; Morton K; O'Shaughnessy F; Sonderlichová S; Farcas A; Janneke GE; Sturkenboom MC; Trifirò G
    Drug Saf; 2024 Jun; ():. PubMed ID: 38907947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ChAdOx1 nCoV-19 Vaccine Side Effects among Healthcare Workers in Trinidad and Tobago.
    Gopaul CD; Ventour D; Thomas D
    Vaccines (Basel); 2022 Mar; 10(3):. PubMed ID: 35335098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of side-effects associated with the booster dose of Pfizer-BioNTech (BNT162b2) of COVID-19 Vaccine among vaccinated adults in the Eastern province of Saudi Arabia.
    Al-Matouq JA; Ali MD; Al-Somali SM; Ahmad A; Banu N; Patel M
    Infect Prev Pract; 2022 Dec; 4(4):100251. PubMed ID: 36276167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perceptions and experiences of COVID-19 vaccines' side effects among healthcare workers at an Egyptian University Hospital: a cross-sectional study.
    Orebi HA; Emara HE; Alhindi AA; Shahin MR; Hegazy AH; Kabbash IA; Saied SM
    Trop Med Health; 2022 May; 50(1):37. PubMed ID: 35637513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 Vaccine Booster Hesitancy in Malaysia: A Web-Based Cross-Sectional Study.
    Lee KW; Yap SF; Ong HT; Oo M; Swe KMM
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Side effects and perceptions following Sinopharm COVID-19 vaccination.
    Saeed BQ; Al-Shahrabi R; Alhaj SS; Alkokhardi ZM; Adrees AO
    Int J Infect Dis; 2021 Oct; 111():219-226. PubMed ID: 34384899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acceptance of COVID-19 Vaccine Booster Doses Using the Health Belief Model: A Cross-Sectional Study in Low-Middle- and High-Income Countries of the East Mediterranean Region.
    Ghazy RM; Abdou MS; Awaidy S; Sallam M; Elbarazi I; Youssef N; Fiidow OA; Mehdad S; Hussein MF; Adam MF; Abdullah FSA; Rebai WK; Raad EB; Hussein M; Shehata SF; Ismail II; Salam AA; Samhouri D
    Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low uptake of COVID-19 vaccines in Wad Medani City, Gezira State, Sudan: Hesitancy and poor accessibility.
    Elmustafa M; Wedaa A; Babiker H; Elmajzoup A; Ali H; Ahmed R
    Vaccine X; 2023 Dec; 15():100369. PubMed ID: 37649618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Traditional Chinese medicine auricular point acupressure for the relief of pain, fatigue, and gastrointestinal adverse reactions after the injection of novel coronavirus-19 vaccines: a structured summary of a study protocol for a multicentre, three-arm, single-blind, prospective randomized controlled trial.
    Fu Q; Xie H; Zhou L; Li X; Liu Y; Liu M; Wang C; Wang X; Wang Z; Tang J; Xiao H; Xiao Z; Zhou J; Feng C; Wang L; Ao Z; Chen X; Su C; Wu X; Zhao M; Hu S; Lin H; Huang J; Xu G; Zhang Q; Jiang L
    Trials; 2021 Feb; 22(1):162. PubMed ID: 33632286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surveillance of Post-Vaccination Side Effects of COVID-19 Vaccines among Saudi Population: A Real-World Estimation of Safety Profile.
    Alzarea AI; Khan YH; Alatawi AD; Alanazi AS; Alzarea SI; Butt MH; Almalki ZS; Alahmari AK; Mallhi TH
    Vaccines (Basel); 2022 Jun; 10(6):. PubMed ID: 35746532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between COVID-19 vaccines and development of chronic morbidities: a cross-sectional study in the Jordanian population.
    Al-Hawamdeh MI; Abu-Huwaij R; Astiti TA; Al-Debe'e AK; Abazeed OJ; Raees MA
    Curr Med Res Opin; 2024 Mar; 40(3):537-543. PubMed ID: 38193825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequency and Nuisance Level of Adverse Events in Individuals Receiving Homologous and Heterologous COVID-19 Booster Vaccine.
    Rzymski P; Sikora D; Zeyland J; Poniedziałek B; Kiedik D; Falfushynska H; Fal A
    Vaccines (Basel); 2022 May; 10(5):. PubMed ID: 35632510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Side Effects of COVID-19 Pfizer-BioNTech mRNA Vaccine in Children Aged 12-18 Years in Saudi Arabia.
    Alamer E; Alhazmi A; Qasir NA; Alamer R; Areeshi H; Gohal G; Qadri M; Hashem AM; Algaissi A
    Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835228
    [No Abstract]   [Full Text] [Related]  

  • 40. Side Effects and Perceptions Following COVID-19 Vaccination in Jordan: A Randomized, Cross-Sectional Study Implementing Machine Learning for Predicting Severity of Side Effects.
    Hatmal MM; Al-Hatamleh MAI; Olaimat AN; Hatmal M; Alhaj-Qasem DM; Olaimat TM; Mohamud R
    Vaccines (Basel); 2021 May; 9(6):. PubMed ID: 34073382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.